Precipio Launches HemeScreen Molecular Test for Hematologic Cancers
The test challenges a $100 million annual US laboratory market by reducing costs through a simple, screening assay.
Read More
Search Results for: genetic testing
Determining Molecular Response in Chronic Myeloid Leukemia
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read More
FDA Recommendations on the Use of Genetic Testing
In a safety communication issued at the beginning of November 2018, FDA alerted patients and healthcare providers that many claims about the ability of direct-to-consumer pharmacogenetic tests to predict a patient’s response to specific medications have not been reviewed by the agency, and may not be supported by scientific or clinical evidence for most medications.
Read More
From the Editor: Test Consumer, Beware
At the beginning of November FDA issued a safety communication to alert the public about concerns regarding DTC genetic tests with unapproved claims.
Read MoreInterpace Diagnostics Presents Data from Multicenter Registry Study of Thyroid Cancer
Researchers presented data from clinical experience study of ThyGenX and ThyraMIR testing at the annual meeting of the American Thyroid Association.
Read More